ID Source | ID |
---|---|
PubMed CID | 91687 |
CHEBI ID | 81728 |
SCHEMBL ID | 36679 |
MeSH ID | M0399879 |
Synonym |
---|
aniloguard |
s-4-chloro-n-isopropylcarbaniloylmethyl o,o-dimethyl phosphorodithioate |
einecs 264-756-5 |
o,o-dimethyl s-(2-((4-chlorophenyl)(1-methylethyl)amino)-2-oxoethyl)phosphorodithioate |
phosphorodithioic acid, s-(2-((4-chlorophenyl)(1-methylethyl)amino)-2-oxoethyl)-, o,o-dimethyl ester |
hoe 574 |
anilophos |
s-4-chloro-n-isopropylcarbanilolylmethyl o,o-dimethyl phosphorodithioate |
arozin |
s-(2-((4-chlorophenyl)(isopropyl)amino)-2-oxoethyl) o,o-dimethyl dithiophosphate |
rico |
s-(2-((4-chlorophenyl)(1-methylethyl)amino)-2-oxoethyl) o,o-dimethyl phosphorodithioate |
hoe 30374 |
brn 2395778 |
anilofos [bsi:iso] |
anilofos |
64249-01-0 |
n-(4-chlorophenyl)-2-dimethoxyphosphinothioylsulfanyl-n-propan-2-ylacetamide |
C18394 |
unii-71w48u40s6 |
71w48u40s6 , |
FT-0630746 |
AKOS015895538 |
anilofos [iso] |
SCHEMBL36679 |
CHEBI:81728 |
DTXSID5058149 |
s-(2-((4-chlorophenyl)(isopropyl)amino)-2-oxoethyl) o,o-dimethyl phosphorodithioate |
NXQDBZGWYSEGFL-UHFFFAOYSA-N |
anilofos, pestanal(r), analytical standard |
anilofos 10 microg/ml in isooctane |
s-2-((4-chlorophenyl)(isopropyl)amino)-2-oxoethyl o,o-dimethyl phosphorodithioate |
HY-B2016 |
Q16760606 |
CS-0014115 |
aniloguard; aniloguard 30ec; arozin; hoe 30374; hoe 574 |
F81300 |
anilofos 1000 microg/ml in methanol |
phosphorodithioic acid, s-[2-[(4-chlorophenyl)(1-methylethyl)amino]-2-oxoethyl] o,o-dimethyl ester |
s-[2-(4-chloro-n-isopropylanilino)-2-oxoethyl]-o,o'-dimethyl dithiophosphate |
Anilofos is a widely used thionoorganophosphate herbicide. malathion is an insecticide.
Excerpt | Reference | Relevance |
---|---|---|
"Anilofos is an organophosphate compound and is used extensively as a preemergence and early postemergence herbicide for the management of sedges, annual grasses, and some broad-leaved weeds in rice fields. " | ( Assessment of anilofos-induced mutagenicity in bone marrow and germ cells of Swiss albino mice. Bagri, P; Kumar, V, 2020) | 2.36 |
"Anilofos is a widely used thionoorganophosphate herbicide, while malathion is a thionoorganophosphate insecticide." | ( Influence of malathion pretreatment on the toxicity of anilofos in male rats: a biochemical interaction study. Hajare, S; Hazarika, A; Kataria, M; Malik, JK; Sarkar, SN, 2003) | 1.29 |
Excerpt | Reference | Relevance |
---|---|---|
" Oral LD50 was 1681 mg/kg." | ( Subacute toxicity of anilofos, a new organophosphorus herbicide, in male rats: effect on some physical attributes and acetylcholinesterase activity. Hazarika, A; Sarkar, SN, 2001) | 0.63 |
"Sets of 346 herbicides in use and 163 no longer in use were collected from open access online sources and compared in silico with cholinesterases inhibitors (ChI) and drugs in terms of physicochemical profile and estimated toxic effects on human health." | ( Selected herbicides screened for toxicity and analysed as inhibitors of both cholinesterases. Katalinić, M; Kolić, D; Kovarik, Z; Pehar, V; Šinko, G; Stepanić, V; Zandona, A, 2023) | 0.91 |
Class | Description |
---|---|
anilide | Any aromatic amide obtained by acylation of aniline. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.47) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |